Skip to main content
TipRanks
Go Ultimate75% OFF

Aprogen Biologics (003060) Revenue

Aprogen Biologics Revenue

Aprogen Biologics had a revenue of 23.08B in the quarter ending Jun 30, 2026, with 6.75%. This bring the company's revenue in the last twelve months to 86.18B, Increased 10.49%. In the fiscal year ending Dec 31, 2025, Aprogen Biologics had annual revenue of 73.23B with 8.68% growth.

Revenue (ttm)
86.18B
Revenue Growth
17.80%
P/S Ratio
0.48
Revenue/Employee
KRW 194,233,793
Employees
377
Market Cap
KRW 35.43B

Revenue Chart

Aprogen Biologics Revenue - Annual

020B40B60B80B100B46.10B45.40B50.90B53.32B56.48B65.19B87.36B67.38B73.23B201720182019202020212022202320242025
Revenue History
Download to Excel
KR:003060 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202573.23B5.85B8.68%
Dec 31, 202467.38B-19.99B-22.88%
Dec 31, 202387.36B22.17B34.01%
Dec 31, 202265.19B8.71B15.42%
Dec 31, 202156.48B3.16B5.93%
Dec 31, 202053.32B2.42B4.75%
Dec 31, 201950.90B5.51B12.13%
Dec 31, 201845.40B-705.56M-1.53%
Dec 31, 201746.10B――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
KR:00306086.18B
KR:068760536.40B
KR:0696201.68T
KR:170900860.94B
KR:18349067.75B
KR:249420582.33B